According to Cardiac Healthcare, recently, the company's Hector® /Tsutenji® thoracic aortic multi-branch laminating stent system and Cratos® /Tsutensana® branched aortic stent system successfully completed their first clinical application at Toronto General Hospital in Canada, achieving the first commercial implementation of the company's products in Canada.

According to Cardiac Healthcare, recently, the company's Hector® /Tsutenji® thoracic aortic multi-branch laminating stent system and Cratos® /Tsutensana® branched aortic stent system successfully completed their first clinical application at Toronto General Hospital in Canada, achieving the first commercial implementation of the company's products in Canada.